drugset / Trial / NCT05503875
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
NaSingle-groupOpen-labelTreatment
Summary
Through the combination of clinical manifestations and omics, the investigators aim to explore the skin cell atlas in different stages of psoriasis lesions, establish a clinical classification standard for psoriasis, and guide the precise treatment of psoriasis.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | — | — |
| Subject | Guselkumab | Monoclonal antibody | — | — |
| Subject | Ixekizumab | Monoclonal antibody | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Secukinumab | Monoclonal antibody | — | — |